Logo (Genotropin 01)
Genotropin Kit
Product Images NDC 0013-2649
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Genotropin (NDC 0013-2649). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure A (Genotropin 02)
An instructional diagram labeled Figure A showing components of a two-chamber cartridge injection system. The diagram identifies the outer needle cover, inner needle cover, needle, needle thread, rubber stopper, two-chamber cartridge, liquid, growth hormone, finger grip, and plunger rod in sequence, illustrating assembly details for the injection device.*
Figure B (Genotropin 03)
An instructional illustration showing two hands preparing a syringe. One hand holds the syringe barrel while the other hand grasps a vial, suggesting the process of drawing medication into the syringe, likely for injection.*
Figure C (Genotropin 04)
An instructional diagram showing components of a needle, including the outer needle cover, inner needle cover, needle, and seal. The illustration is clear and labeled for each part, intended to aid understanding of needle assembly or usage.*
Figure D (Genotropin 05)
Instructional line drawing illustrating the proper technique to twist or unlock a cap or component on an injectable pen or syringe device, involving one hand holding the device below and the other hand twisting the top part.*
Figure E (Genotropin 06)
An instructional line drawing showing a hand holding a syringe, spinning the plunger. This illustration appears to demonstrate the technique for preparing or adjusting the syringe before injection, relevant to the GENOTROPIN somatropin kit by Pfizer Laboratories.*
Figure F (Genotropin 07)
An instructional illustration showing front and back views of a human torso highlighting areas suitable for injection. Shaded areas include the upper outer thigh, abdomen, and upper buttocks. This figure likely guides injection site selection for GENOTROPIN (somatropin) administration.*
Figure G (Genotropin 08)
An instructional illustration showing the correct method to draw medication from a vial into a syringe using two hands. The left panel depicts inserting the needle into the vial and pulling back the plunger, and the right panel shows holding the vial and syringe in preparation to extract the liquid.*
Figure H (Genotropin 09)
An instructional diagram showing a hand holding a syringe and injecting into skin, illustrating the injection process.*
Figure I (Genotropin 10)
An instructional illustration showing a person injecting medication with a syringe. The hand on the left supports the injection site while the right hand holds the syringe, angled downward. This image is part of a kit for administering medication.*
Principal Display Panel (0.4 mg Cartridge Label)
Label for Genotropin 0.4 mg (somatropin) for injection, a growth hormone delivery device. It is a product of Pharmacia & Upjohn Co, a division of Pfizer Inc, NY, NY. The label includes space for lot number and expiration date, as well as barcodes and the NDC 0013-2650-01.*
Principal Display Panel (0.4 mg Kit Carton)
Carton packaging label for GENOTROPIN 0.4 mg MiniQuick (somatropin) for injection, a growth hormone delivery device intended for single subcutaneous injection. It is a 7-pack kit labeled by Pfizer Laboratories Div Pfizer Inc. The label includes dosage strength, usage instructions, and manufacturer information.*
Principal Display Panel (0.6 mg Cartridge Label)
Label for Genotropin 0.6 mg (somatropin) for injection. The label identifies it as a Genotropin MiniQuick Growth Hormone Delivery Device. It includes the NDC number 0013-2651-01 and lists Pharmacia & Upjohn Co, a division of Pfizer Inc, located in New York, NY. The label also features a lot number field, expiration date field, and a barcode.*
Principal Display Panel (0.6 mg Kit Carton)
Packaging label for Genotropin 0.6 mg (somatropin) MiniQuick, a growth hormone delivery device for single subcutaneous injection only. The kit is labeled for prescription use and contains 7 packs. The product is manufactured by Pfizer Laboratories Div Pfizer Inc.*
Principal Display Panel (0.8 mg Cartridge Label)
Label for GENOTROPIN 0.8 mg (somatropin) for injection, presented as a kit. It features the Genotropin MiniQuick Growth Hormone Delivery Device. The label shows the NDC number 0013-2652-01 and identifies the manufacturer as Pharmacia & Upjohn Co, a division of Pfizer Inc, NY, NY.*
Principal Display Panel (0.8 mg Kit Carton)
Box packaging label for Genotropin MiniQuick 0.8 mg, somatropin for injection, a growth hormone delivery device. The label indicates a 7-pack, single subcutaneous injection only, and shows Pfizer as the labeler. The design includes the product name, strength, dosage form, and usage instructions on the carton layout.*
Principal Display Panel (1 mg Cartridge Label)
Label for GENOTROPIN 1 mg (somatropin) injection kit. It includes the product name, strength, and method of delivery via Genotropin MiniQuick growth hormone delivery device. Label shows the NDC number 0013-2653-01 and identifies Pharmacia & Upjohn Co, a division of Pfizer Inc, New York, NY as the labeler.*
Principal Display Panel (1 mg Kit Carton)
GENOTROPIN 1 mg MiniQuick kit, a growth hormone delivery device containing somatropin for injection. The packaging indicates it is for single subcutaneous injection only and contains a 7-pack. The labeler is Pfizer Laboratories Div Pfizer Inc.*
Principal Display Panel (1.2 mg Cartridge Label)
Label for Genotropin 1.2 mg (somatropin) injection kit. It indicates the product is a Genotropin MiniQuick Growth Hormone Delivery Device manufactured by Pharmacia & Upjohn Co, a division of Pfizer Inc, NY. The label includes the NDC 0013-2654-01, a lot number, and spaces for expiration date.*
Principal Display Panel (1.2 mg Kit Carton)
GENOTROPIN 1.2 mg MiniQuick kit packaging label for somatropin injection. It includes branding by Pfizer and specifies it is for single subcutaneous injection only using a growth hormone delivery device. The package contains 7 packs and is labeled as prescription only.*
Figure J (Genotropin 11)
Illustration showing hands preparing an injection with a syringe and vial, likely demonstrating the process associated with use of GENOTROPIN (somatropin) kit. The image focuses on the technique of drawing medication from the vial into the syringe.*
Principal Display Panel (1.4 mg Cartridge Label)
Label for GENOTROPIN 1.4 mg kit containing somatropin for injection. The product is described as a Growth Hormone Delivery Device from Pharmacia & Upjohn Co, a division of Pfizer Inc., New York, NY. The label also shows an NDC number and space for lot and expiration information, along with a barcode.*
Principal Display Panel (1.4 mg Kit Carton)
Box packaging label for GENOTROPIN 1.4 mg MiniQuick, somatropin for injection. The label indicates it is for single subcutaneous injection only and is a growth hormone delivery device. The package contains 7 packs and is labeled by Pfizer Laboratories Div Pfizer Inc. The front features the brand name prominently with dosage strength and injection instructions.*
Principal Display Panel (1.6 mg Cartridge Label)
Label for Genotropin 1.6 mg (somatropin) injection kit, featuring the Genotropin MiniQuick growth hormone delivery device. Label includes product NDC 0013-2656-01 and identification codes, with manufacturer listed as Pharmacia & Upjohn Co, division of Pfizer Inc, NY.*
Principal Display Panel (1.6 mg Kit Carton)
Packaging label for Genotropin 1.6 mg Kit containing somatropin for injection by Pfizer. The label specifies this is a Genotropin MiniQuick growth hormone delivery device for single subcutaneous injection, available in a 7 pack. The label includes dosage form, strength, RX only designation, and manufacturer details.*
Principal Display Panel (1.8 mg Cartridge Label)
Label for GENOTROPIN 1.8 mg (somatropin) for injection, a human prescription drug. The label identifies the product as Genotropin MiniQuick Growth Hormone Delivery Device, manufactured by Pharmacia & Upjohn Co, a division of Pfizer Inc, NY, NY. The label includes spaces for lot number and expiration date and features a barcode.*
Principal Display Panel (1.8 mg Kit Carton)
Box label for GENOTROPIN 1.8 mg Genotropin MiniQuick (somatropin) for injection, a kit designed for single subcutaneous injection using a growth hormone delivery device. The packaging indicates a 7 pack kit labeled by Pfizer Laboratories Div Pfizer Inc, with clear branding, dosage, and usage instructions.*
Principal Display Panel (2 mg Cartridge Label)
Label for Genotropin 2 mg (somatropin) injection, a growth hormone delivery device. The label indicates the product is manufactured by Pharmacia & Upjohn Co, a division of Pfizer Inc, NY, NY. It includes an NDC code 0013-2658-01, barcode, and spaces for lot number and expiration date.*
Principal Display Panel (2 mg Kit Carton)
Packaging label for Genotropin MiniQuick 2 mg kit for injection, containing somatropin. This Pfizer product is a growth hormone delivery device intended for single subcutaneous injections. The package is a 7-pack, labeled for prescription use only, with the NDC 0013-2658-02 clearly shown.*
Logo (Genotropin 12)
Logo (Genotropin 13)
GENOTROPIN MiniQuick Growth Hormone Delivery Device label showing the brand name Genotropin and MiniQuick, indicating it contains somatropin for injection. The label includes the PHARMACIA logo and describes the product as a growth hormone delivery device containing Genotropin (somatropin).*
Logo (Genotropin 14)
GENOTROPIN Pen 12 kit packaging label showing the brand name Genotropin, describing it as a growth hormone delivery device for use with Genotropin (somatropin) for injection. The label indicates it is a delivery device, not the drug vial itself, from Pfizer Laboratories Div Pfizer Inc.*
Figure A (Genotropin 15)
An illustration diagram showing the components of a GENOTROPIN somatropin injection pen kit. Labeled parts include the needle guard, front cap, outer and inner needle covers, needle, metal front part, cartridge window, indicative scale, plunger rod window, plastic body, clip on panel, dose display, injection button, cartridge with rubber stopper, and red release button.*
Figure B (Genotropin 16)
An instructional illustration showing the removal of a protective cap from a GENOTROPIN pen device. A hand is depicted pulling the cap away, indicated by a red arrow pointing left, suggesting the cap should be pulled off before use.*
Figure C (Genotropin 17)
An instructional illustration showing hands holding a device labeled GENOTROPIN, with a red arrow indicating a twisting or turning action on part of the device, likely as part of assembly or preparation steps.*
Figure D (Genotropin 18)
An instructional illustration demonstrating how to remove the cap from a pen injector device, highlighting the twisting motion needed to detach the cap. The image shows hands gripping the device and the cap with an arrow indicating the direction to turn.*
Figure E (Genotropin 19)
GENOTROPIN kit showing the front view of the product components. The image focuses on the somatropin delivery pen and its associated label markings. The label includes barcode and dosing details typically associated with the Pfizer Laboratories Div Pfizer Inc product packaging.*
Figure F (Genotropin 20)
An instructional illustration showing two hands, one holding a capped syringe-like device at the top and the other holding a vial at the bottom. A red arrow points upward between the vial and the syringe, indicating the action of attaching or inserting the syringe device onto the vial, likely part of assembly or preparation for use.*
Figure G (Genotropin 21)
An instructional diagram showing two views of a medical device or pen with a red circular button. The left view includes a red arrow pointing to the button, indicating an action to press or interact with it. The right view shows a front-facing perspective of the device highlighting the circular button.*
Figure H (Genotropin 22)
An instructional illustration showing a hand peeling back a protective seal labeled with a black arrow on a device, likely part of the GENOTROPIN somatropin kit by Pfizer Laboratories. A red arrow indicates the direction to lift or remove the seal.*
Figure I (Genotropin 23)
An instructional diagram showing the use or assembly of a device, possibly related to the administration of GENOTROPIN (somatropin) human prescription drug kit. The image depicts a close-up line drawing focusing on a specific part or step without text or additional context.*
Figure J (Genotropin 24)
An instructional diagram showing a person holding a Genotropin somatropin kit component, demonstrating how to twist or turn a part as indicated by a curved red arrow. The illustration likely guides users on preparing or assembling the medication kit for use.*
Figure K (Genotropin 25)
An instructional illustration showing a hand holding a GENOTROPIN pen device, demonstrating the motion to twist the pen. Arrows indicate the direction to turn the pen mechanism as part of its use instructions.*
Figure L (Genotropin 26)
An illustration of a GENOTROPIN kit component showing a close-up view of a cartridge or injector pen with a labeled area for dosage or identification. The image highlights the detailed section of the product, emphasizing its use as a human prescription drug kit by Pfizer Laboratories Div Pfizer Inc.*
Figure M (Genotropin 27)
An instructional illustration showing the use of an injection device with an arrow indicating the direction to push or press a component. This image likely accompanies directions for administering the product device in the GENOTROPIN somatropin kit by Pfizer Laboratories Div Pfizer Inc.*
Figure N (Genotropin 28)
An instructional line drawing shows a hand holding a GENOTROPIN cartridge or delivery device with an arrow pointing upward along the device, indicating a direction for operation or adjustment. This is part of the kit for administering somatropin.*
Figure O (Genotropin 29)
An instructional illustration showing a hand interacting with a device labeled with 'mg'. The image depicts pressing a button while an arrow curves upward, indicating a motion or action to be performed on the device. The illustration is likely part of directions for use or device operation guidance in the GENOTROPIN somatropin kit.*
Figure P (Genotropin 30)
An instructional illustration showing a person preparing a GENOTROPIN somatropin injection kit. The image depicts hands handling the injection device and a vial, with a red arrow indicating the direction to assemble or connect parts of the kit.*
Image (Genotropin 31)
Figure Q (Genotropin 32)
An instructional diagram showing a close-up of a finger pressing a pin into the side of a cartridge labeled with a numeric dose display reading '00 mg.' An arrow points upward from the cartridge, indicating the action of pushing the pin to set or prepare the dose. This likely illustrates part of the preparation or administration process for the GENOTROPIN somatropin KIT.*
Figure R (Genotropin 33)
An instructional diagram showing two injection sites on the human body. The first site is the back of the upper arm, indicated by a circle. The second site is the outer thigh, also marked by a circle. Both illustrations highlight appropriate areas for subcutaneous administration.*
Figure S (Genotropin 34)
An instructional illustration showing a hand holding a Genotropin somatropin pen device and administering an injection into the skin of another person's arm. The image demonstrates the proper technique for subcutaneous injection using the Genotropin kit.*
Figure T (Genotropin 35)
An instructional illustration showing two hands preparing an injection device. One hand is holding a vial or cartridge, and the other is handling a syringe or pen injector, demonstrating how to attach or prepare the injection component, likely related to the GENOTROPIN somatropin kit by Pfizer Laboratories.*
Figure U (Genotropin 36)
Instructional illustration showing a person holding a GENOTROPIN somatropin kit. One hand holds the pen-like device, while the other hand pulls the red-capped needle cover away, indicating preparation for injection.*
Figure V (Genotropin 37)
GENOTROPIN kit label showing the proprietary name GENOTROPIN prominently. The image includes a focus on a vial with a numeric display, likely indicating dosage or volume, within a red circle. The label also shows the labeler Pfizer Laboratories Division Pfizer Inc. The kit format is visible with associated measurement markings.*
Figure W (Genotropin 38)
An instructional illustration showing a close-up of hands assembling or preparing a GENOTROPIN somatropin injection kit. The image focuses on connecting or attaching a red-capped component to a syringe or similar device, demonstrating part of the medication preparation process.*
Figure X (Genotropin 39)
An instructional illustration showing a hand pressing on the red circular button of a GENOTROPIN somatropin drug delivery pen. The inset highlights the red button on the pen's plunger mechanism, indicating the step to activate or release the medication from the device.*
Figure Y (Genotropin 40)
An instructional illustration showing a hand inserting or removing a needle cover from an injection device. The image highlights the action with a red arrow indicating the direction of movement.*
Figure Z (Genotropin 41)
An instructional diagram showing a hand rotating the black dosing knob of a GENOTROPIN somatropin injection pen, illustrating how to set the dose before administration.*
Figure Aa (Genotropin 42)
An instructional illustration showing a person preparing an injection pen by attaching a needle. The person holds the pen in one hand and is holding a needle cap in the other hand, aligning it for attachment as indicated by a red arrow.*
Image (Genotropin 43)
GENOTROPIN kit label showing a digital display screen reading "1.4". The kit is a human prescription drug containing somatropin, manufactured by Pfizer Laboratories Div Pfizer Inc.*
Image (Genotropin 44)
Image (Genotropin 45)
GENOTROPIN KIT by Pfizer Laboratories Div Pfizer Inc, a human prescription drug containing somatropin. The image shows a rectangular device or component likely part of the kit, featuring two small circular ports or holes on its surface, set within a white rectangular background with a black border.*
Image (Genotropin 46)
Image (Genotropin 47)
GENOTROPIN kit packaging label from Pfizer Laboratories Div Pfizer Inc, featuring a simple rectangular container with segmented compartments. The packaging does not display additional text or dosage details in the visible image.*
Image (Genotropin 48)
GENOTROPIN kit by Pfizer Laboratories contains somatropin as the active ingredient. The image shows a rectangular container with three compartments, likely designed to hold components of the drug kit. No additional text or strength information is visible on the container.*
Image (Genotropin 49)
GENOTROPIN somatropin kit packaging label. The label features the proprietary name GENOTROPIN and generic name somatropin. The kit is indicated as a human prescription drug, with the labeler listed as Pfizer Laboratories Div Pfizer Inc. The packaging includes a rectangular transparent area showing five white, oblong tablets arranged in two rows, three on top and two on the bottom, separated by black divisions.*
Image (Genotropin 50)
Image (Genotropin 51)
Image (Genotropin 52)
Logo (Genotropin 53)
Logo (Genotropin 54)
GENOTROPIN Pen 5 is a growth hormone delivery device kit designed for use with GENOTROPIN (somatropin) injection. This human prescription drug product is labeled by Pfizer Laboratories Div Pfizer Inc. The packaging emphasizes the Pen as a delivery device for somatropin.*
Figure A (Genotropin 55)
Illustration diagram of the GENOTROPIN somatropin drug delivery kit showing labeled components, including the needle guard, front cap, outer needle cover, inner needle cap, needle, cartridge with rubber stopper, metal front part, cartridge window, indicative scale, plunger rod window, plastic body with clip on panel, dose display, injection button, and red release button.*
Figure B (Genotropin 56)
An instructional diagram showing a hand holding a pen-like device with the other hand removing its protective cap, indicated by a red arrow pointing away from the device tip.*
Figure C (Genotropin 57)
An instructional illustration showing how to remove or open a component of the Genotropin somatropin kit. The image depicts hands holding a kit part with an arrow indicating a twisting or pulling motion to open or separate the piece.*
Figure D (Genotropin 58)
An instructional illustration showing a person using their hands to manipulate a small device or vial, with a red arrow indicating a specific direction or action to take, likely part of an administration or preparation process for the GENOTROPIN somatropin kit.*
Figure E (Genotropin 59)
GENOTROPIN somatropin kit packaging label showing a rectangular vial and a packaging box. The vial is depicted with measurement markings, and the labeler is Pfizer Laboratories Div Pfizer Inc. The kit format is indicated by the components shown together in the image.*
Figure F (Genotropin 60)
Illustration showing hands demonstrating the removal of a cartridge or vial by pulling it upward from a holder, likely part of instructions for assembling or using the GENOTROPIN somatropin kit.*
Figure G (Genotropin 61)
An instructional illustration showing a hand holding a device with a black top, positioned next to a finger pressing a red circular button or dial on the device. The image likely demonstrates how to operate or adjust the device included in the GENOTROPIN somatropin kit by Pfizer Laboratories.*
Figure H (Genotropin 62)
An instructional illustration showing a hand holding a device, with an arrow indicating the removal or lifting of a protective cap or cover from the device. The device includes a display screen showing dosage information and a button or dial for adjustment, likely part of the GENOTROPIN somatropin kit.*
Figure I (Genotropin 63)
GENOTROPIN kit by Pfizer Laboratories contains somatropin as the active ingredient. The image shows a portion of the packaging, highlighting a partial view of the product container inside the box. The kit format and Pfizer labeler are indicated.*
Figure J (Genotropin 64)
An instructional illustration showing a hand twisting the red cap off a GENOTROPIN somatropin kit pen device, indicating the removal of the cap by rotating it counterclockwise.*
Figure K (Genotropin 65)
An instructional illustration showing a hand holding a GENOTROPIN pen device and demonstrating rotation of its dial or cap, indicated by a curved arrow. This diagram likely depicts a step in preparing or adjusting the somatropin injectable kit for administration.*
Figure L (Genotropin 66)
Illustration of a GENOTROPIN (somatropin) injection device, showing a close-up of the dosing window where the dose level is displayed. The diagram highlights the dose adjustment area on the pen-type injector included in the GENOTROPIN kit by Pfizer Laboratories.*
Figure M (Genotropin 67)
Illustration showing a hand pressing the injection button of an injectable drug delivery pen, demonstrating the injection process for a KIT dosage form of GENOTROPIN (somatropin). The image guides users on proper injection technique.*
Figure N (Genotropin 68)
An instructional illustration showing a hand holding and operating a GENOTROPIN somatropin kit device. The image depicts the user pressing the device downward on a surface, with a red arrow indicating the direction of motion.*
Figure O (Genotropin 69)
An instructional illustration showing a close-up of a GENOTROPIN somatropin kit device. It depicts a finger pressing a black button with an arrow symbol indicated by a red circular arrow above, suggesting a twisting or turning motion as part of the device's operation or setup process.*
Figure P (Genotropin 70)
Instructional illustration showing hands attaching a needle cap to a GENOTROPIN somatropin injection pen in a kit format. An arrow indicates the direction to push the cap onto the pen before use.*
Image (Genotropin 71)
Figure Q (Genotropin 72)
An instructional diagram showing a hand pressing a button or lever on a digital device, likely part of the GENOTROPIN somatropin kit. The device includes a digital display showing '00 mg' and an arrow indicating the action to press upwards or push the part indicated.*
Figure R (Genotropin 73)
An anatomical diagram showing recommended injection sites for a medication. The labeled areas include the outer thigh, abdomen around the navel, upper arm, and buttocks, indicated on both front and back views of a human figure.*
Figure S (Genotropin 74)
Illustration depicting the use of a pen injector device held in one hand, with the opposite hand preparing or injecting into the skin. The image likely shows the technique of administering an injection, relevant to a drug delivery device such as GENOTROPIN somatropin kit.*
Figure T (Genotropin 75)
An instructional illustration showing two hands assembling or preparing a device by connecting two parts, with a red arrow indicating the direction of attachment. No text or labeling is visible in the image.*
Figure U (Genotropin 76)
An instructional diagram showing how to connect or assemble parts of a device, with a hand holding a pen-like device and an arrow indicating a rotation or twisting motion to attach the parts.*
Figure V (Genotropin 77)
An instructional illustration showing a syringe, with a red circle highlighting a section near the needle base, likely indicating a specific part or step in the device's use. The diagram emphasizes detail on the syringe components relevant for administration.*
Figure W (Genotropin 78)
An instructional illustration showing a hand preparing an injection by removing a red cap from a vial or syringe, suggesting a step in medication administration or preparation for use.*
Figure X (Genotropin 79)
An instructional illustration showing a hand pressing a button or component on a device, with a red arrow indicating the action to be performed. A smaller inset shows a close-up view of the device's button or component being pressed.*
Figure Y (Genotropin 80)
An instructional diagram showing how to operate a GENOTROPIN somatropin injection pen. The illustration depicts a dosing window on the pen displaying a dose in milligrams (mg), and a hand adjusting the dose by turning a red dial or knob to set the desired amount.*
Figure Z (Genotropin 81)
An instructional illustration showing hands preparing a syringe, with an arrow indicating the removal of the syringe cap by twisting or pulling it off. The image is part of a kit likely related to injection preparation for the product GENOTROPIN (somatropin).*
Figure Aa (Genotropin 82)
An instructional illustration showing hands preparing an injection pen by removing a protective cap, indicated by a red arrow. The image demonstrates the first step in assembling or readying the device, likely part of the GENOTROPIN somatropin kit.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
